Zevra Therapeutics (ZVRA) Stock Price & Financial Analysis
Zevra Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Zevra Therapeutics
What is the current stock price for ZVRA?
As of the latest trading session, ZVRA stock trades at $9.40. The 52-week range is $6.19–$13.16, with a day range of $9.15–$9.44.
What is the P/E ratio for ZVRA?
Zevra Therapeutics's trailing P/E ratio is 6.5, meaning investors pay $6.5 for every $1 of annual earnings. Zevra Therapeutics operates in the Healthcare sector.
Does ZVRA pay dividends?
Zevra Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZVRA?
Based on 1 analyst, the consensus for ZVRA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ZVRA?
Zevra Therapeutics's market capitalization is $538.3M, classifying it as a small-cap company. Zevra Therapeutics operates in the Healthcare sector within the Biotechnology industry.